Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-γ

被引:136
作者
Inoue, M [1 ]
Itoh, H [1 ]
Tanaka, T [1 ]
Chun, TH [1 ]
Doi, K [1 ]
Fukunaga, Y [1 ]
Sawada, N [1 ]
Yamshita, J [1 ]
Masatsugu, K [1 ]
Saito, T [1 ]
Sakaguchi, S [1 ]
Sone, M [1 ]
Yamahara, K [1 ]
Yurugi, T [1 ]
Nakao, K [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Sakyo Ku, Kyoto 6068507, Japan
关键词
vascular endothelial growth factors; atherosclerosis; macrophages; endothelial cells; peroxisome proliferator-activated receptor-gamma;
D O I
10.1161/01.ATV.21.4.560
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vascular endothelial growth factor (VEGF) has been recognized as an angiogenic factor that induces endothelial proliferation and vascular permeability. Recent studies have also suggested that VEGF can promote macrophage migration, which is critical for atherosclerosis. We have reported that VEGF is remarkably expressed in activated macrophages, endothelial cells, and smooth muscle cells within human coronary atherosclerotic lesions, and we have proposed the significance of VEGF in the progression of atherosclerosis. To clarify the mechanism of VEGF expression in atherosclerotic lesions, we examined the regulation of VEGF expression by oxidized low density lipoprotein (Ox-LDL), which is abundant in atherosclerotic arterial walls. A recent report has revealed that peroxisome proliferator-activated receptor-gamma (PPAR gamma) is expressed not only in adipocytes but also in monocytes/macrophages and has suggested that PPAR gamma may have a role in the differentiation of monocytes/macrophages. Furthermore, 9- and 13-hydroxy-(S)-10,12-octadecadienoic acid (9- and 13-HODE, respectively), the components of Ox-LDL, may be PPAR gamma ligands. Therefore, we investigated the involvement of PPAR gamma in the regulation of VEGF by Ox-LDL. PPAR gamma expression was detected in human monocyte/macrophage cell lines, human acute monocytic leukemia (THP-1) cells, and human coronary artery endothelial cells (HCAECs). Ox-LDL (10 to 50 mug/mL) upregulated VEGF secretion from THP-1 dose-dependently. VEGF mRNA expression in HCAECs was also upregulated by Ox-LDL. The mRNA expression of VEGF in THP-1 cells and HCAECs was also augmented by PPAR gamma activators, troglitazone (TRO), and 15-deoxy-Delta (12,14)-prostaglandin J(2) (PGJ2). In contrast, VEGF expression in another monocyte/macrophage cell line, human histiocytic lymphoma cells (U937), which lacks PPAR gamma expression, was not augmented by TRO or PGJ2. We established the U937 cell line, which permanently expresses PPAR gamma (U937T). TRO and Ox-LDL augmented VEGF expression in U937T. In addition, VEGF production by THP-1 cells was significantly increased by exposure to 9-HODE and 13-HODE. In conclusion, Ox-LDL upregulates VEGF expression in macrophages and endothelial cells, at least in part, through the activation of PPAR gamma.
引用
收藏
页码:560 / 566
页数:7
相关论文
共 42 条
[11]   ENHANCED MACROPHAGE DEGRADATION OF LOW-DENSITY LIPOPROTEIN PREVIOUSLY INCUBATED WITH CULTURED ENDOTHELIAL-CELLS - RECOGNITION BY RECEPTORS FOR ACETYLATED LOW-DENSITY LIPOPROTEINS [J].
HENRIKSEN, T ;
MAHONEY, EM ;
STEINBERG, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (10) :6499-6503
[12]   Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions - Possible pathophysiological significance of VEGF in progression of atherosclerosis [J].
Inoue, M ;
Itoh, H ;
Ueda, M ;
Naruko, T ;
Kojima, A ;
Komatsu, R ;
Doi, K ;
Ogawa, Y ;
Tamura, N ;
Takaya, K ;
Igaki, T ;
Yamashita, J ;
Chun, TH ;
Masatsugu, K ;
Becker, AE ;
Nakao, K .
CIRCULATION, 1998, 98 (20) :2108-2116
[13]  
INOUE M, 1997, CIRCULATION S1, V96, P2
[14]   Hypertension and insulin resistance:: Role of peroxisome proliferator-activated receptor γ [J].
Itoh, H ;
Doi, K ;
Tanaka, T ;
Fukunaga, Y ;
Hosoda, K ;
Inoue, G ;
Nishimura, H ;
Yoshimasa, Y ;
Yamori, Y ;
Naka, K .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1999, 26 (07) :558-560
[15]   PROBUCOL PREVENTS THE PROGRESSION OF ATHEROSCLEROSIS IN WATANABE HERITABLE HYPERLIPIDEMIC RABBIT, AN ANIMAL-MODEL FOR FAMILIAL HYPERCHOLESTEROLEMIA [J].
KITA, T ;
NAGANO, Y ;
YOKODE, M ;
ISHII, K ;
KUME, N ;
OOSHIMA, A ;
YOSHIDA, H ;
KAWAI, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (16) :5928-5931
[16]   DIFFERENTIAL EXPRESSION AND ACTIVATION OF A FAMILY OF MURINE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS [J].
KLIEWER, SA ;
FORMAN, BM ;
BLUMBERG, B ;
ONG, ES ;
BORGMEYER, U ;
MANGELSDORF, DJ ;
UMESONO, K ;
EVANS, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (15) :7355-7359
[17]   IMPAIRMENT OF ENDOTHELIUM-DEPENDENT ARTERIAL RELAXATION BY LYSOLECITHIN IN MODIFIED LOW-DENSITY LIPOPROTEINS [J].
KUGIYAMA, K ;
KERNS, SA ;
MORRISETT, JD ;
ROBERTS, R ;
HENRY, PD .
NATURE, 1990, 344 (6262) :160-162
[18]   Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia [J].
Law, RE ;
Meehan, WP ;
Xi, XP ;
Graf, K ;
Wuthrich, DA ;
Coats, W ;
Faxon, D ;
Hsueh, WA .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (08) :1897-1905
[19]   THE NUCLEAR RECEPTOR SUPERFAMILY - THE 2ND DECADE [J].
MANGELSDORF, DJ ;
THUMMEL, C ;
BEATO, M ;
HERRLICH, P ;
SCHUTZ, G ;
UMESONO, K ;
BLUMBERG, B ;
KASTNER, P ;
MARK, M ;
CHAMBON, P ;
EVANS, RM .
CELL, 1995, 83 (06) :835-839
[20]   Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells [J].
Marx, N ;
Schönbeck, U ;
Lazar, MA ;
Libby, P ;
Plutzky, J .
CIRCULATION RESEARCH, 1998, 83 (11) :1097-1103